Investor Portal
This area is restricted to verified investors
Need access? Contact [email protected]
Investor Relations
Building the future of biofeedback breathing technology
Company Metrics
15,000+
Waitlist Signups
+312% MoM
$2.5M
Pre-Seed Target
Q1 2025
85%
User Retention
Beta Testers
$150B
TAM
Global Wellness
Investment Opportunity
Halcytone is revolutionizing personal wellness through scientifically-backed biofeedback breathing technology.
- B2C SaaS model with recurring revenue
- Proprietary algorithms and biofeedback technology
- Strategic partnerships with wellness platforms
- Experienced team with exits in health tech
Use of Funds
- 40% - Product Development
- 30% - Marketing & Growth
- 20% - Team Expansion
- 10% - Operations
Milestones
- Q1 2026: Beta Launch
- Q2 2026: 50K Users
- Q3 2026: Series A
- Q4 2026: B2B Launch
Get in Touch
Interested in learning more? We'd love to hear from you.
Direct Contact: [email protected]